NCT06943833 - A Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (IVOLGA) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

March 31, 2028

Study Completion Date

March 30, 2029

Conditions

Locally Advanced Cervical Cancer

Interventions

BIOLOGICAL

Volrustomig

IV infusion

Trial Locations (15)

111123

RECRUITING

Research Site, Moscow

115478

RECRUITING

Research Site, Moscow

115533

RECRUITING

Research Site, Moscow

117997

RECRUITING

Research Site, Moscow

NOT_YET_RECRUITING

Research Site, Moscow

125284

RECRUITING

Research Site, Moscow

125367

RECRUITING

Research Site, Moscow

163045

RECRUITING

Research Site, Arkhangelsk

194291

RECRUITING

Research Site, Saint Petersburg

197758

RECRUITING

Research Site, Saint Petersburg

NOT_YET_RECRUITING

Research Site, Saint Petersburg

450054

RECRUITING

Research Site, Ufa

454087

RECRUITING

Research Site, Chelyabinsk

620036

RECRUITING

Research Site, Yekaterinburg

660133

RECRUITING

Research Site, Krasnoyarsk